On Tuesday, PainReform Ltd (NASDAQ: PRFX) opened lower -15.20% from the last session, before settling in for the closing price of $0.31. Price fluctuations for PRFX have ranged from $0.29 to $5.15 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 53.92% at the time writing. With a float of $2.92 million, this company’s outstanding shares have now reached $3.47 million.
In an organization with 7 employees, it is important to assess its efficiency. In terms of profitability, gross margin is -166659512925868.62%, operating margin of -1.7475720455383152e+17%, and the pretax margin is -1.731788409314167e+17%.
PainReform Ltd (PRFX) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Drug Manufacturers – Specialty & Generic industry is another important factor to consider. The insider ownership of PainReform Ltd is 15.78%, while institutional ownership is 8.68%.
PainReform Ltd (PRFX) Latest Financial update
If we go through the results of last quarter, which was made public on 3/31/2024, the company posted -1.7 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -1.6) by -0.1. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.79 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 53.92% per share during the next fiscal year.
PainReform Ltd (NASDAQ: PRFX) Trading Performance Indicators
Check out the current performance indicators for PainReform Ltd (PRFX). In the past quarter, the stock posted a quick ratio of 0.61.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -8.29, a number that is poised to hit -1.10 in the next quarter and is forecasted to reach -2.01 in one year’s time.
Technical Analysis of PainReform Ltd (PRFX)
Let’s dig in a bit further. During the last 5-days, its volume was 7.61 million. That was better than the volume of 0.38 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 21.27%. Additionally, its Average True Range was 0.07.
During the past 100 days, PainReform Ltd’s (PRFX) raw stochastic average was set at 1.12%, which indicates a significant decrease from 9.97% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 109.04% in the past 14 days, which was lower than the 110.62% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.4447, while its 200-day Moving Average is $1.4734. However, in the short run, PainReform Ltd’s stock first resistance to watch stands at $0.4272. Second resistance stands at $0.5910. The third major resistance level sits at $0.6859. If the price goes on to break the first support level at $0.1685, it is likely to go to the next support level at $0.0736.
PainReform Ltd (NASDAQ: PRFX) Key Stats
There are currently 2,026K shares outstanding in the company with a market cap of 0.91 million. Presently, the company’s annual sales total 0 K according to its annual income of -9,340 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -7,310 K.
